A detailed history of Captrust Financial Advisors transactions in Royalty Pharma PLC stock. As of the latest transaction made, Captrust Financial Advisors holds 30,924 shares of RPRX stock, worth $799,385. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,924
Previous 33,459 7.58%
Holding current value
$799,385
Previous $1.02 Million 19.78%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$26.26 - $29.9 $66,569 - $75,796
-2,535 Reduced 7.58%
30,924 $815,000
Q1 2024

May 15, 2024

SELL
$27.46 - $31.33 $153,473 - $175,103
-5,589 Reduced 14.31%
33,459 $1.02 Million
Q4 2023

Feb 14, 2024

SELL
$26.21 - $29.22 $468,425 - $522,219
-17,872 Reduced 31.4%
39,048 $1.1 Million
Q3 2023

Nov 14, 2023

SELL
$26.26 - $31.38 $124,603 - $148,898
-4,745 Reduced 7.69%
56,920 $1.54 Million
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $769 - $950
26 Added 0.04%
61,665 $1.9 Million
Q1 2023

May 15, 2023

SELL
$32.77 - $39.4 $131,047 - $157,560
-3,999 Reduced 6.09%
61,639 $2.22 Million
Q4 2022

Feb 15, 2023

BUY
$39.17 - $44.04 $58,128 - $65,355
1,484 Added 2.31%
65,638 $2.59 Million
Q3 2022

Nov 16, 2022

BUY
$39.88 - $44.65 $2.55 Million - $2.85 Million
63,866 Added 22175.69%
64,154 $2.58 Million
Q2 2022

Aug 23, 2022

SELL
$37.53 - $44.22 $19,403 - $22,861
-517 Reduced 64.22%
288 $12,000
Q2 2022

Aug 16, 2022

BUY
$37.53 - $44.22 $20,491 - $24,144
546 Added 210.81%
805 $34,000
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $4,195 - $4,753
112 Added 76.19%
259 $10,000
Q4 2021

Feb 14, 2022

SELL
$35.17 - $42.48 $2,110 - $2,548
-60 Reduced 28.99%
147 $6,000
Q3 2021

Nov 16, 2021

BUY
$36.14 - $42.24 $7,228 - $8,448
200 Added 2857.14%
207 $7,000
Q2 2021

Aug 16, 2021

BUY
$39.85 - $46.63 $278 - $326
7 New
7 $0

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.3B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.